Ontology highlight
ABSTRACT: Background
Antibodies against phospholipase A2 receptor 1 (PLA2R1) are found in 80% of patients with membranous nephropathy, and previous studies described three autoantibody-targeted PLA2R1 epitope regions. Although anti-PLA2R1 antibody levels are closely associated with treatment response and disease prognosis, the clinical role of epitope regions targeted by autoantibodies is unclear.Methods
In a prospective cohort of 150 patients with newly diagnosed PLA2R1-associated membranous nephropathy, we investigated the clinical role of epitope-recognition patterns and domain-specific PLA2R1 antibody levels by western blot and ELISA.Results
We identified a fourth epitope region in the CTLD8 domain of PLA
SUBMITTER: Reinhard L
PROVIDER: S-EPMC6935013 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature